{"title":"c-MYC/METTL3/LINC01006正反馈回路促进非小细胞肺癌癌症的迁移、侵袭和增殖。","authors":"","doi":"10.1016/j.bj.2023.100664","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><p>This study aims to clarify the N6-methyladenosine (m6A) modification of <em>LINC01006</em>, which is involved in migration, invasion and proliferation of non-small cell lung cancer (NSCLC).</p></div><div><h3>Materials and methods</h3><p><em>LINC01006</em> and <em>METTL3</em> expressions were analyzed in TCGA-LUAD cohort. Colony formation assay, wound-healing assay and transwell assay were performed to evaluate the ability of colony formation, migration and invasion. Q-PCR and western blot analysis determined gene expressions. M6A-RNA immunoprecipitation and m6A quantification assay were used to evaluate m6A modification. qChIP assay was used to validate transcriptional target. Luciferase assay validated the miRNA targets and transcriptional targets. In-situ xenograft model were included to evaluate tumor proliferation <em>in vivo</em>.</p></div><div><h3>Results</h3><p><em>LINC01006</em> and METTL3 expressions were elevated in NSCLC cells and tissues. <em>LINC01006</em> promoted the migration and invasion of NSCLC via epithelial – mesenchymal transition (EMT). The expression of <em>LINC01006</em> was positively correlated to the expression of <em>METTL3</em>. METTL3 promoted tumor formation and proliferation in the in-situ xenograft model of NSCLC. The expression of <em>LINC01006</em> was increased by METTL3 via m6A modification. c-MYC directly induced <em>METTL3</em>. Both <em>c-MYC</em> and <em>LINC01006</em> were commonly targeted by miR-34a/b/c and miR-2682, and thereby c-MYC/METTL3/<em>LINC01006</em> formed a positive feedback loop through miRNA targets in NSCLC.</p></div><div><h3>Conclusions</h3><p><em>LINC01006</em> is an oncogenic lncRNA, which induces migration, invasion and proliferation of NSCLC. METTL3 increases <em>LINC01006</em> expression through stabilizing <em>LINC0</em>1006 mRNA. c-MYC, as a transcription factor, activates METTL3, which results in an elevated level of <em>LINC01006</em>. c-MYC, METTL3 and <em>LINC01006</em> form a positive feedback loop through multiple miRNA targets in NSCLC.</p></div>","PeriodicalId":8934,"journal":{"name":"Biomedical Journal","volume":"47 4","pages":"Article 100664"},"PeriodicalIF":4.1000,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2319417023001014/pdfft?md5=0de141ccded89abb4cf91afb0ff9abb8&pid=1-s2.0-S2319417023001014-main.pdf","citationCount":"0","resultStr":"{\"title\":\"c-MYC/METTL3/LINC01006 positive feedback loop promotes migration, invasion and proliferation of non-small cell lung cancer\",\"authors\":\"\",\"doi\":\"10.1016/j.bj.2023.100664\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background</h3><p>This study aims to clarify the N6-methyladenosine (m6A) modification of <em>LINC01006</em>, which is involved in migration, invasion and proliferation of non-small cell lung cancer (NSCLC).</p></div><div><h3>Materials and methods</h3><p><em>LINC01006</em> and <em>METTL3</em> expressions were analyzed in TCGA-LUAD cohort. Colony formation assay, wound-healing assay and transwell assay were performed to evaluate the ability of colony formation, migration and invasion. Q-PCR and western blot analysis determined gene expressions. M6A-RNA immunoprecipitation and m6A quantification assay were used to evaluate m6A modification. qChIP assay was used to validate transcriptional target. Luciferase assay validated the miRNA targets and transcriptional targets. In-situ xenograft model were included to evaluate tumor proliferation <em>in vivo</em>.</p></div><div><h3>Results</h3><p><em>LINC01006</em> and METTL3 expressions were elevated in NSCLC cells and tissues. <em>LINC01006</em> promoted the migration and invasion of NSCLC via epithelial – mesenchymal transition (EMT). The expression of <em>LINC01006</em> was positively correlated to the expression of <em>METTL3</em>. METTL3 promoted tumor formation and proliferation in the in-situ xenograft model of NSCLC. The expression of <em>LINC01006</em> was increased by METTL3 via m6A modification. c-MYC directly induced <em>METTL3</em>. Both <em>c-MYC</em> and <em>LINC01006</em> were commonly targeted by miR-34a/b/c and miR-2682, and thereby c-MYC/METTL3/<em>LINC01006</em> formed a positive feedback loop through miRNA targets in NSCLC.</p></div><div><h3>Conclusions</h3><p><em>LINC01006</em> is an oncogenic lncRNA, which induces migration, invasion and proliferation of NSCLC. METTL3 increases <em>LINC01006</em> expression through stabilizing <em>LINC0</em>1006 mRNA. c-MYC, as a transcription factor, activates METTL3, which results in an elevated level of <em>LINC01006</em>. c-MYC, METTL3 and <em>LINC01006</em> form a positive feedback loop through multiple miRNA targets in NSCLC.</p></div>\",\"PeriodicalId\":8934,\"journal\":{\"name\":\"Biomedical Journal\",\"volume\":\"47 4\",\"pages\":\"Article 100664\"},\"PeriodicalIF\":4.1000,\"publicationDate\":\"2024-08-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.sciencedirect.com/science/article/pii/S2319417023001014/pdfft?md5=0de141ccded89abb4cf91afb0ff9abb8&pid=1-s2.0-S2319417023001014-main.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Biomedical Journal\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2319417023001014\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"BIOCHEMISTRY & MOLECULAR BIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biomedical Journal","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2319417023001014","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
c-MYC/METTL3/LINC01006 positive feedback loop promotes migration, invasion and proliferation of non-small cell lung cancer
Background
This study aims to clarify the N6-methyladenosine (m6A) modification of LINC01006, which is involved in migration, invasion and proliferation of non-small cell lung cancer (NSCLC).
Materials and methods
LINC01006 and METTL3 expressions were analyzed in TCGA-LUAD cohort. Colony formation assay, wound-healing assay and transwell assay were performed to evaluate the ability of colony formation, migration and invasion. Q-PCR and western blot analysis determined gene expressions. M6A-RNA immunoprecipitation and m6A quantification assay were used to evaluate m6A modification. qChIP assay was used to validate transcriptional target. Luciferase assay validated the miRNA targets and transcriptional targets. In-situ xenograft model were included to evaluate tumor proliferation in vivo.
Results
LINC01006 and METTL3 expressions were elevated in NSCLC cells and tissues. LINC01006 promoted the migration and invasion of NSCLC via epithelial – mesenchymal transition (EMT). The expression of LINC01006 was positively correlated to the expression of METTL3. METTL3 promoted tumor formation and proliferation in the in-situ xenograft model of NSCLC. The expression of LINC01006 was increased by METTL3 via m6A modification. c-MYC directly induced METTL3. Both c-MYC and LINC01006 were commonly targeted by miR-34a/b/c and miR-2682, and thereby c-MYC/METTL3/LINC01006 formed a positive feedback loop through miRNA targets in NSCLC.
Conclusions
LINC01006 is an oncogenic lncRNA, which induces migration, invasion and proliferation of NSCLC. METTL3 increases LINC01006 expression through stabilizing LINC01006 mRNA. c-MYC, as a transcription factor, activates METTL3, which results in an elevated level of LINC01006. c-MYC, METTL3 and LINC01006 form a positive feedback loop through multiple miRNA targets in NSCLC.
期刊介绍:
Biomedical Journal publishes 6 peer-reviewed issues per year in all fields of clinical and biomedical sciences for an internationally diverse authorship. Unlike most open access journals, which are free to readers but not authors, Biomedical Journal does not charge for subscription, submission, processing or publication of manuscripts, nor for color reproduction of photographs.
Clinical studies, accounts of clinical trials, biomarker studies, and characterization of human pathogens are within the scope of the journal, as well as basic studies in model species such as Escherichia coli, Caenorhabditis elegans, Drosophila melanogaster, and Mus musculus revealing the function of molecules, cells, and tissues relevant for human health. However, articles on other species can be published if they contribute to our understanding of basic mechanisms of biology.
A highly-cited international editorial board assures timely publication of manuscripts. Reviews on recent progress in biomedical sciences are commissioned by the editors.